| Bioactivity | TD-1 (Transdermal peptide) is a short peptide that can promote the delivery of macromolecule drugs, especially protein drugs, through the skin barrier. TD-1 can significantly improve the transdermal delivery efficiency of protein drugs such as insulin and human growth hormone, allowing them to reach systemic circulation. Research on TD-1 transdermal drug delivery system[1]. |
| CAS | 918629-48-8 |
| Sequence | Ala-Cys-Ser-Ser-Ser-Pro-Ser-Lys-His-Cys-Gly |
| Shortening | ACSSSPSKHCG |
| Formula | C40H66N14O16S2 |
| Molar Mass | 1063.17 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Chen Y, et al. Transdermal protein delivery by a coadministered peptide identified via phage display[J]. Nature biotechnology, 2006, 24(4): 455-460. |
TD-1
CAS: 918629-48-8 F: C40H66N14O16S2 W: 1063.17
TD-1 (Transdermal peptide) is a short peptide that can promote the delivery of macromolecule drugs, especially protein d
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.